CNS and Metabolic Established private clinical trials site with two decades of experience conducting early to late-stage studies in CNS and metabolic diseases, including schizophrenia, depression, addiction, PTSD, diabetes and hypertension. This depth positions Uptown Research Institute as a strong, dedicated partner for pharma sponsors seeking reliable site access for mental health and metabolic programs across Phases one through three.

Geography Advantage Chicago-based location provides access to a diverse patient population in the Midwest and solid regulatory familiarity, offering sponsors a regional hub for patient recruitment and site operations.

Operational Readiness As a mid-sized, experienced site with an established revenue stream, Uptown can commit dedicated trial capacity and sponsor-focused site management for targeted programs, enabling faster start-up and consistent data collection.

Tech Enabled Trials Technology stack signals readiness for digital trial components such as online enrollment, remote engagement, and data integration; opportunities to expand with electronic data capture, eConsent and integrated data management to streamline trials.

Partnership Potential Market positioning as Chicagoland's premier private clinical trials site provides a compelling basis for long-term sponsorships, exclusive site partnerships, or multi-site collaborations, especially for CNS and metabolic portfolios seeking reliable, experienced study sites.